The Archaea is similar to the Eukarya in the following characteristic except?initiator 1RNA (protein synthesis)O 16S FRNA nucleotide sequencesensitivity to antibioticstypes of RNA polymeraseThe Archaea differ from the Eubacteria in the following characteristicexcept: *O initiator tRNA (protein synthesis)origin of DNA replicationsensitivity to antibioticstypes of RNA polymerase

1) Both Archae and Eukarya have an initiator tRNA with an unmodified methionine in protein…

The Archaea is similar to the Eukarya in the following characteristic except? O initiator TRNA (protein synthesis) O 168 FRNA nucleotide sequence O sensitivity to antibiotics O types of RNA polymerase The Archaea differ from the Eubacteria in the following characteristic except: * O initiator TRNA (protein synthesis) O origin of DNA replication O sensitivity to antibiotics O types of RNA polymerase

The Archaea is similar to the Eukarya in the following characteristic except? O initiator TRNA (protein synthesis) O 168 FRNA nucleotide sequence O sensitivity to antibiotics O types of RNA polymerase The Archaea differ from the Eubacteria in the following characteristic except: * O initiator TRNA (protein synthesis) O origin of DNA replication O sensitivity to antibiotics O types of RNA polymerase

Biology 2e

2nd Edition

ISBN:9781947172517

Author:Matthew Douglas, Jung Choi, Mary Ann Clark

Publisher:Matthew Douglas, Jung Choi, Mary Ann Clark

Chapter20: Phylogenies And The History Of Life

Section: Chapter Questions

Problem 13RQ: Particles that transfer genetic material from one species to another, especially in marine...

See similar textbooks

Similar questions

Each species of bacteria has its own distinctive cell surface. Thecharacteristics of the cell surface play an important role in processessuch as conjugation and transduction. For example, certainstrains of E. coli have pili on their cell surface. These pili enableE. coli to conjugate with other E. coli and also enable certain bacteriophages (such as M13) to bind to the surface of the E. coli andgain entry into the cytoplasm. With these ideas in mind, explainwhich forms of genetic transfer (i.e., conjugation, transduction,and transformation) are more likely to occur between different speciesof bacteria. Discuss some of the potential consequences ofinterspecies genetic transfer.
Why are bacterial DNA gyrase and topoisomerase good targets for antimicrobial drugs? These enzymes are not necessary for DNA replication. These enzymes are involved in energy production, so targeting them would prevent the bacteria from obtaining necessary energy. These enzymes are different from their eukaryotic counterparts, so the drugs targeting them should not affect the host. These enzymes are responsible for host cell recognition, so targeting them would prevent the host cell from being infected.Flag this QuestionQuestion 10
Some scientists are trying to engineer bacteriophageto treat bacterial infections in humans when theinfections do not respond to chemical antibiotics.a. What possible advantages might phage therapyhave over antibiotic therapy?
DNA replication is critical to the growth of microbes. describe themechanism used by prokaryotes to duplicate their DNA
In Hershey and Chase’s experiment investigating which biological molecule carries genetic information, they found that phage DNA with radiolabeled phosphorus was retained in bacterial cells after transduction. To conclude that DNA is the genetic material, what assumption did they have to make? A. Protein does not enter the bacterium during transduction. B. DNA does not stay in the media after transduction. C. All of the phage DNA was radiolabeled. D. Bacteria can be transduced by phage.
Archaea (formerly known as archaebacteria) is one of the three major divisions of living organisms; the other two are eubacteria and eukaryotes. Nanoarchaeum equitans is in the Archaea domain and has one of the smallest genomes known, about 0.5 Mb. How can an organism complete its life cycle with so little genetic material?
Antibiotics and Protein Synthesis Antibiotics are molecules produced by microorganisms as defense mechanisms. The most effective antibiotics work by interfering with essential biochemical or reproductive processes. Many antibiotics block or disrupt one or more stages in protein synthesis. Some of these are mentioned here. Tetracyclines are a family of chemically related compounds used to treat several types of bacterial infections. Tetracyclines interfere with the initiation of translation. The tetracycline molecule attaches to the small ribosomal subunit and prevents binding of the tRNA anticodon during initiation. Both eukaryotic and prokaryotic ribosomes are sensitive to the action of tetracycline, but this antibiotic cannot pass through the plasma membrane of eukaryotic cells. Because tetracycline can enter bacterial cells to inhibit protein synthesis, it will stop bacterial growth, helping the immune system fight the infection. Streptomycin is used in hospitals to treat serious bacterial infections. It binds to the small ribosomal subunit but does not prevent initiation or elongation; however, it does affect the efficiency of protein synthesis. Binding of streptomycin changes the way mRNA codons interact with the tRNA. As a result, incorrect amino acids are incorporated into the growing polypeptide chain, producing nonfunctional proteins. In addition, streptomycin causes the ribosome to randomly fall off the mRNA, preventing the synthesis of complete proteins. Puromycin is not used clinically but has played an important role in studying the mechanism of protein synthesis in the research laboratory. The puromycin molecule is the same size and shape as a tRNA/amino acid complex. When puromycin enters the ribosome, it can be incorporated into a growing polypeptide chain, stopping further synthesis because no peptide bond can be formed between puromycin and an amino acid, causing the shortened polypeptide to fall off the ribosome. Chloramphenicol was one of the first broadspectrum antibiotics introduced. Eukaryotic cells are resistant to its actions, and it was widely used to treat bacterial infections. However, its use is limited to external applications and serious infections. Chloramphenicol destroys cells in the bone marrow, the source of all blood cells. In bacteria, this antibiotic binds to the large ribosomal subunit and inhibits the formation of peptide bonds. Another antibiotic, erythromycin, also binds to the large ribosomal subunit and inhibits the movement of ribosomes along the mRNA. Almost every step of protein synthesis can be inhibited by one antibiotic or another. Work on designing new synthetic antibiotics to fight infections is based on our knowledge of how the nucleotide sequence of mRNA is converted into the amino acid sequence of a protein. Questions Why are antibiotics ineffective in treating the common cold and other virus infections?
Particles that transfer genetic material from one species to another, especially in marine prokaryotes horizontal gene transfer lateral gene transfer genome fusion device gene transfer agents
Antibiotics and Protein Synthesis Antibiotics are molecules produced by microorganisms as defense mechanisms. The most effective antibiotics work by interfering with essential biochemical or reproductive processes. Many antibiotics block or disrupt one or more stages in protein synthesis. Some of these are mentioned here. Tetracyclines are a family of chemically related compounds used to treat several types of bacterial infections. Tetracyclines interfere with the initiation of translation. The tetracycline molecule attaches to the small ribosomal subunit and prevents binding of the tRNA anticodon during initiation. Both eukaryotic and prokaryotic ribosomes are sensitive to the action of tetracycline, but this antibiotic cannot pass through the plasma membrane of eukaryotic cells. Because tetracycline can enter bacterial cells to inhibit protein synthesis, it will stop bacterial growth, helping the immune system fight the infection. Streptomycin is used in hospitals to treat serious bacterial infections. It binds to the small ribosomal subunit but does not prevent initiation or elongation; however, it does affect the efficiency of protein synthesis. Binding of streptomycin changes the way mRNA codons interact with the tRNA. As a result, incorrect amino acids are incorporated into the growing polypeptide chain, producing nonfunctional proteins. In addition, streptomycin causes the ribosome to randomly fall off the mRNA, preventing the synthesis of complete proteins. Puromycin is not used clinically but has played an important role in studying the mechanism of protein synthesis in the research laboratory. The puromycin molecule is the same size and shape as a tRNA/amino acid complex. When puromycin enters the ribosome, it can be incorporated into a growing polypeptide chain, stopping further synthesis because no peptide bond can be formed between puromycin and an amino acid, causing the shortened polypeptide to fall off the ribosome. Chloramphenicol was one of the first broadspectrum antibiotics introduced. Eukaryotic cells are resistant to its actions, and it was widely used to treat bacterial infections. However, its use is limited to external applications and serious infections. Chloramphenicol destroys cells in the bone marrow, the source of all blood cells. In bacteria, this antibiotic binds to the large ribosomal subunit and inhibits the formation of peptide bonds. Another antibiotic, erythromycin, also binds to the large ribosomal subunit and inhibits the movement of ribosomes along the mRNA. Almost every step of protein synthesis can be inhibited by one antibiotic or another. Work on designing new synthetic antibiotics to fight infections is based on our knowledge of how the nucleotide sequence of mRNA is converted into the amino acid sequence of a protein. Questions Why is targeting protein synthesis an effective strategy for preventing infection?
Peptidoglycan is a chemical compound found in the cell walls of (a) most viroids (b) most archaea (c) all prokaryotes (d) most bacteria (e) most eukarya
________ can have a genome of either RNA or DNA. a. Bacteria b. Eukaryotes c. Viruses d. Archaea
Microbiologists have announced the discovery of over 30 new species of bacteria that thrive between the teeth and gums of humans. The bacteria could not be grown in the researcher's laboratories, nor were any of them ever observed via and kind of microscopy. If they couldn't culture them or see them, how could the researchers know they discovered a new species? If they couldn't examine the cells for the presence of a nucleus, how did they determine that the organisms were prokaryotes and not eukaryotes?